Today we announced new Phase 3 data in children living with hypochondroplasia, which were published in NEJM Evidence and featured in a late-breaking oral presentation at #ESPE2026.

These findings reflect our continued commitment to advancing research in skeletal conditions and deepening scientific understanding of #hypochondroplasia, a form of skeletal dysplasia that can impact growth, physical function and everyday life for children and families.

Learn more: http://ms.spr.ly/6011akPav